Login / Signup

Stated Preferences for Attributes of a CYP2C19 Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario.

Basil G BerezaDoug CoyleDerek Y F SoZbigniew KadziolaGeorge WellsPaul GrootendorstEmmanuel A Papadimitropoulos
Published in: ClinicoEconomics and outcomes research : CEOR (2020)
This translational study shows preference for a point of care PGx test.
Keyphrases
  • acute coronary syndrome
  • percutaneous coronary intervention
  • decision making